Central nervous system active 5-oxo-1,4,5,6,7,8-hexahydrocinnolines

Area of Science:

• Medicinal Chemistry
• Neuropharmacology

Background:

• Hexahydrocinnoline derivatives are investigated for potential therapeutic applications.
• Central nervous system (CNS) activity is a key area of focus in drug discovery.

Purpose of the Study:

• To synthesize and evaluate novel hexahydrocinnoline derivatives for CNS activity.
• To identify compounds with potential sedative, anticonvulsant, and antidepressant properties.

Main Methods:

• Synthesis of a series of 5-oxo-1,4,5,6,7,8-hexahydrocinnoline compounds.
• Evaluation of CNS activity, including sedative, anticonvulsant, and antidepressant assays.
• Assessment of safety margins for promising compounds.

Main Results:

• Compounds 23 and 27 exhibited sedative and anticonvulsant properties, along with activity in antidepressant models.
• These compounds possessed a narrow safety margin, limiting their therapeutic potential.
• Derivatives 35-38 showed activity in antidepressant tests and weak sedative effects, but lacked anticonvulsant properties.

Conclusions:

• Certain hexahydrocinnoline derivatives demonstrate promising CNS activity, including antidepressant potential.
• Safety profiles are critical for the development of CNS-active agents.
• Further research into structural modifications may yield compounds with improved therapeutic indices.